Felix (fangyong) Du
VP
pharmaceutical
Adagene
China
Biography
Dr. Felix (Fangyong) Du is the Vice President of Technology Development at Adagene. He has over 20 years of experience in biological research and discovery, and has published numerous peer-reviewed articles, including original articles in world-renowned scientific journals such as Nature and Science. His discoveries were featured on the cover of Nature and critically reviewed with high praise by prominent scientists in the field. Before joining Adagene, Dr. Du worked at Affomix, a biotech startup by Yale professors that specializes in high throughput discovery of antibodies against human proteome. He created an innovative technology platform for high throughput preparation and oriented presentation of antigens. After acquisition of Affomix by Illumina Inc., Dr. Du continued to develop new technologies in protein and nucleic acid chemistry.
Research Interest
pharmaceutical
